Science Current Events | Science News | Brightsurf.com
 

Extra-aggressive form of idiopathic pulmonary fibrosis identified

May 30, 2007
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly.

Now, Selman and coworkers present in an article published in the online, open-access journal PLoS ONE on Wednesday 30th May, strong evidence indicating that a subset of IPF patients has a short duration of symptoms before diagnosis and display an accelerated clinical course to end-stage disease. The authors postulate that these "rapid progressor" patients, predominantly smoking males, represent a distinct clinical phenotype compared with the usual "slow progressors" patients.

"These findings highlight the variability in the progression and outcome of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF," said Dr Selman, who is the Director of Research at the National Institute of Respiratory Research in Mexico City and the lead author on this publication. "They also suggest that physicians should pay more attention to the time of onset of symptoms, and to look for other signs that allow the identification of these rapid progressor patients".

In this study the authors performed global gene expression analysis and other molecular studies in a subset of patients and identified a number of genes that were differentially expressed in both groups, suggesting that rapid progressors are biologically distinct from slow progressors.

"While preliminary, these results may allow investigators to identify biomarkers of disease progression," said Dr King, who is the Chief of Medicine at San Francisco General Hospital and an internationally renowned expert in research and management of pulmonary fibrosis.

The senior author on this paper, Dr Naftali Kaminski, who is the Director of the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh, added that this research highlighted the need to collect as much information on patients with IPF as possible. "We are only now starting to really understand the disease and characterize it," he said, "therefore, it is critical for patients with the disease to be seen in centers that are actively involved in IPF research."

Better identification and understanding of these differences may provide insights into the pathogenesis of IPF and assist in the development of therapeutic interventions for this devastating lung disease.

Public Library of Science


Related Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles


Rapid skin improvement seen after treating systemic sclerosis patients with fresolimumab
A major treatment breakthrough for total body scarring of the skin that occurs in patients with systemic sclerosis (SSc), also known as scleroderma, may soon be available for the estimated 300,000 Americans who suffer with this condition.

Study provides insights on chronic lung disease
A new study shows that shorter telomeres--which are the protective caps at the end of a cell's chromosomes--are linked with worse survival in a progressive respiratory disease called idiopathic pulmonary fibrosis (IPF).

UGA researchers find potential treatment for fatal lung diseases
Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal.

New approach for treating idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which as yet no causal therapy exists. It is, however, known that the lung interstitium - the connective tissue between the air sacs in the lower part of the lung - is affected.

Mutations in 2 genes linked to familial pulmonary fibrosis and telomere shortening
Researchers at UT Southwestern Medical Center have identified mutations in two genes that cause a fatal lung scarring disease known as familial pulmonary fibrosis.

New method enables drug target validation for COPD treatment
Together with clinical partners, a team led by Dr. Dr. Melanie Königshoff and the doctoral student Franziska Uhl at the Comprehensive Pneumology Center of Helmholtz Zentrum München have investigated, for the first time, the suitability of Wnt/beta-catenin.

Childhood syndrome combining lung disease, arthritis is identified
Using the latest genome sequencing techniques, a research team led by scientists from UC San Francisco (UCSF), Baylor College of Medicine, and Texas Children's Hospital has identified a new autoimmune syndrome characterized by a combination of severe lung disease and arthritis that currently has no therapy.

Gene in high-altitude cattle disease sheds light on human lung disease
Vanderbilt University researchers have found a genetic mutation that causes pulmonary hypertension in cattle grazed at high altitude, and which leads to a life-threatening condition called brisket disease.

One type of airway cell can regenerate another lung cell type
A new collaborative study describes a way that lung tissue can regenerate after injury.

Premature aging of stem cell telomeres, not inflammation, linked to emphysema
Lung diseases like emphysema and pulmonary fibrosis are common among people with malfunctioning telomeres, the "caps" or ends of chromosomes. Now, researchers from Johns Hopkins say they have discovered what goes wrong and why.
More Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles

Pulmonary Fibrosis: Coping With a Terminal Disease

Pulmonary Fibrosis: Coping With a Terminal Disease
by Lifestyle Design Solutions


Pulmonary Fibrosis: Coping With a Terminal Disease by Robert Post

What do you do when you learn you have Pulmonary Fibrosis, a terminal disease for which there is presently no cure? The author relates his personal experience and explains how he has learned to cope with the disease, products and methods he uses for maintaining health and combating progression of the disease and explains how you can, too.

A linked resources section gives advice on finding and using support groups and Pulmonary Rehabilitation programs. Products and sources are identified that the author has found to be beneficial or vital for health maintenance.

This publication contains frank material that some may find disturbing to read but the author feels the patient and their caregiver...

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis
by Robert Davidson (Author)


Robert Davidson was diagnosed with Idiopathic Pulmonary Fibrosis in October 2007 after having difficulties with the fitness test necessary to retain senior level soccer referee status. Rather than give in to the disease and die, he decided to fight and live as normal a life as possible, borrowing from Winston Churchill, the mantra "Never surrender". He and his wife, Heather, believe it was this attitude that led to him "winning" a double lung transplant January 30, 2010, just weeks before he would have died from the disease. This book is about his journey with that life threatening disease. Although it "steals away the sufferer's breath" Robert travelled to China (finding 12,800 feet up the Himalayas too high) and to the highlands of Scotland for his wife's 60th birthday celebration. ...

Journey of the CareGiver: Battling Pulmonary Fibrosis

Journey of the CareGiver: Battling Pulmonary Fibrosis
by MS, Lois Moody RN (Author)


The latest edition of this book (Surviving Caregiving) is available for the same price at: www.amazon.com/Surviving-Caregiving-Challenges-Lois-Moody/dp/1501029878/ref=sr_1_4?ie=UTF8&qid=1410298234&sr=8-4&keywords=surviving+caregiving

Improving Fibrosis in 30 Days

Improving Fibrosis in 30 Days
by Naturally Healthy Publications


Improving Fibrosis in 30 Days includes a rehabilitation plan to improve your pulmonary fibrosis symptoms and to attain long term health.

Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide (Respiratory Medicine)

Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide (Respiratory Medicine)
by Keith C. Meyer (Editor), Steven D. Nathan (Editor)


Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide delivers a concise review of our current understanding of disease pathogenesis and provides current evidence in the medical literature regarding its diagnosis and management. Each chapter includes key points and a summary aiming to update clinicians about various issues concerning the diagnosis and management of IPF. In addition to outlining the current state of knowledge, each chapter also provides a summary of ongoing research and identifies the needs for future research in the field. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide is an important new text that provides its readers with a better understanding of the pathobiology and natural history of IPF as it continues to evolve.

Saunders Comprehensive Review for the NCLEX-RN® Examination, 6e (Saunders Comprehensive Review for Nclex-Rn)

Saunders Comprehensive Review for the NCLEX-RN® Examination, 6e (Saunders Comprehensive Review for Nclex-Rn)
by Linda Anne Silvestri PhD RN (Author)


Often called the ‘the best NCLEX® exam review book ever,’ Saunders Comprehensive Review for the NCLEX-RN® Examination provides everything you need to prepare for the NCLEX exam - complete content review and over 5,100 NCLEX examination-style questions in the book and online. Don't make the mistake of assuming the quality of the questions is the same in all NCLEX exam review books, because only this book includes the kind of questions that consistently test the critical thinking skills necessary to pass today's NCLEX exam. Even better, all answers include detailed rationales to help you learn from your answer choices, as well as test-taking strategies with tips on how to best approach each question. Written by the most trusted name in NCLEX review, Linda Anne Silvestri, and updated...

Cardiovascular and Pulmonary Physical Therapy: Evidence to Practice, 5e

Cardiovascular and Pulmonary Physical Therapy: Evidence to Practice, 5e
by Donna Frownfelter PT DPT MA CCS RRT FCCP (Author), Elizabeth Dean PhD PT (Author)


Providing a solid foundation in cardiovascular and pulmonary physiology and rehabilitation, Cardiovascular and Pulmonary Physical Therapy: Evidence and Practice, 5th Edition uses the latest scientific literature and research in covering anatomy and physiology, assessment, and interventions. A holistic approach addresses the full spectrum of cardiovascular and pulmonary physical therapy from acute to chronic conditions, starting with care of the stable patient and progressing to management of the more complex, unstable patient. Both primary and secondary cardiovascular and pulmonary disorders are covered. In this edition, updates include new, full-color clinical photographs and the most current coverage of techniques and trends in cardiopulmonary physical therapy. Edited by Donna...

Dr. Pestana's Surgery Notes: Top 180 Vignettes for the Surgical Wards (Kaplan Test Prep)

Dr. Pestana's Surgery Notes: Top 180 Vignettes for the Surgical Wards (Kaplan Test Prep)
by Dr. Carlos Pestana (Author)


Celebrated by medical students for over a decade, Dr. Pestana’s Surgery Notes is the highest-yield surgery review for the shelf and USMLE® Step 2 CK exams.

 

Surgical clerkship allows senior medical students to develop clinical skills and gain a better understanding of surgical disease while caring for patients. But time in the wards is limited, and clerkship covers only a tiny sample of the surgical universe. Dr. Pestana’s Surgery Notes: Top 180 Vignettes for the Surgical Wards, by distinguished surgery instructor Dr. Carlos Pestana, contains the surgery knowledge you need to excel on the Surgery shelf exam and USMLE® Step 2 CK. 

 

— Concise high-yield review of core surgery material

— 180 vignettes for self-testing

— Used by med...

Your Guide to Lung Diseases: A Pulmonologist ExplainsLung Diseases

Your Guide to Lung Diseases: A Pulmonologist ExplainsLung Diseases


This book is written for all with an interest in lung diseases. This includes health care students such as nursing and respiratory students. As this book is written in a manner made understandable to all with a reasonable educational background, readers should also include patients, families, and caregivers. Students and patients are not mutually exclusive. Patients with lung disease should have a workable understanding of themedical issues involved. Students' coursework and clinical time will become more meaningful after reading this book. For patients, I am well aware that time spent in a physician's office is frequently short. There is a schedule to maintain and many issues to be covered. This often results in too little time for a complete discussion of all that needs to be and should...

Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, 5th edition

Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, 5th edition
by Michael Grippi (Author), Jack Elias (Author), Jay Fishman (Author), Allan Pack (Author), Robert Senior (Author), Robert Kotloff (Author)


Turn to the field's definitive text for a thorough understanding of the clinical and scientific aspects of pulmonary medicine Since 1980, Fishman's Pulmonary Diseases and Disorders has delivered unparalleled coverage of pulmonary medicine and the underlying basic and applied science upon which clinical practice is based. The Fifth Edition, with 270 contributing authors, includes over 2,000 illustrations, 60 videos, and 18,000 references. The book opens with a comprehensive overview of the scientific basis of lung function in health and disease. It then provides detailed coverage of the broad array of diseases and disorders affecting the respiratory system, including obstructive and restrictive diseases, pulmonary vascular disorders, sleep-disordered breathing, lung neoplasms, respiratory...

© 2015 BrightSurf.com